KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Healthcare (HCA) over the last 16 years, with Q4 2025 value amounting to $12.0 million.

  • Healthcare's Amortization of Deferred Charges rose 3333.33% to $12.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $44.0 million, marking a year-over-year increase of 2571.43%. This contributed to the annual value of $44.0 million for FY2025, which is 2571.43% up from last year.
  • As of Q4 2025, Healthcare's Amortization of Deferred Charges stood at $12.0 million, which was up 3333.33% from $7.0 million recorded in Q3 2025.
  • Healthcare's 5-year Amortization of Deferred Charges high stood at $14.0 million for Q2 2025, and its period low was $6.0 million during Q2 2021.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $8.0 million (2021), whereas its average is $8.5 million.
  • In the last 5 years, Healthcare's Amortization of Deferred Charges tumbled by 2500.0% in 2021 and then soared by 7500.0% in 2025.
  • Quarter analysis of 5 years shows Healthcare's Amortization of Deferred Charges stood at $6.0 million in 2021, then grew by 16.67% to $7.0 million in 2022, then increased by 28.57% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024, then surged by 33.33% to $12.0 million in 2025.
  • Its Amortization of Deferred Charges stands at $12.0 million for Q4 2025, versus $7.0 million for Q3 2025 and $14.0 million for Q2 2025.